These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38836050)

  • 1. Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome.
    Ravaioli F; Stagni F; Guidi S; Pirazzini C; Garagnani P; Silvani A; Zoccoli G; Bartesaghi R; Bacalini MG
    Front Aging Neurosci; 2024; 16():1401109. PubMed ID: 38836050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts.
    Thomas JR; Sloan K; Cave K; Wallace JM; Roper RJ
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
    Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
    Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
    Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonic vocalization phenotypes in the Ts65Dn and Dp(16)1Yey mouse models of Down syndrome.
    Glass TJ; Lenell C; Fisher EH; Yang Q; Connor NP
    Physiol Behav; 2023 Nov; 271():114323. PubMed ID: 37573959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
    Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
    Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes.
    Hawley LE; Prochaska F; Stringer M; Goodlett CR; Roper RJ
    Pharmacol Biochem Behav; 2022 Jun; 217():173404. PubMed ID: 35576991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
    Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
    Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatiotemporal development of spinal neuronal and glial populations in the Ts65Dn mouse model of Down syndrome.
    Aziz NM; Klein JA; Brady MR; Olmos-Serrano JL; Gallo V; Haydar TF
    J Neurodev Disord; 2019 Dec; 11(1):35. PubMed ID: 31839007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoproteomic Alterations of Ionotropic Glutamate Receptors in the Hippocampus of the Ts65Dn Mouse Model of Down Syndrome.
    Gómez de Salazar M; Grau C; Ciruela F; Altafaj X
    Front Mol Neurosci; 2018; 11():226. PubMed ID: 30140203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome.
    Uguagliati B; Al-Absi AR; Stagni F; Emili M; Giacomini A; Guidi S; Nyengaard JR; Bartesaghi R
    Hippocampus; 2021 Apr; 31(4):435-447. PubMed ID: 33464704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein dynamics associated with failed and rescued learning in the Ts65Dn mouse model of Down syndrome.
    Ahmed MM; Dhanasekaran AR; Block A; Tong S; Costa AC; Stasko M; Gardiner KJ
    PLoS One; 2015; 10(3):e0119491. PubMed ID: 25793384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
    Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Potassium and Cation Channels in Hippocampal Abnormalities of Embryonic Ts65Dn and Tc1 Trisomic Mice.
    Stern S; Segal M; Moses E
    EBioMedicine; 2015 Sep; 2(9):1048-62. PubMed ID: 26501103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased male reproductive success in Ts65Dn "Down syndrome" mice.
    Moore CS; Hawkins C; Franca A; Lawler A; Devenney B; Das I; Reeves RH
    Mamm Genome; 2010 Dec; 21(11-12):543-9. PubMed ID: 21110029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo 1H MRS study in microlitre voxels in the hippocampus of a mouse model of Down syndrome at 11.7 T.
    Santin MD; Valabrègue R; Rivals I; Pénager R; Paquin R; Dauphinot L; Albac C; Delatour B; Potier MC
    NMR Biomed; 2014 Oct; 27(10):1143-50. PubMed ID: 25088227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
    Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
    Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.
    Keck-Wherley J; Grover D; Bhattacharyya S; Xu X; Holman D; Lombardini ED; Verma R; Biswas R; Galdzicki Z
    Dev Neurosci; 2011; 33(5):451-67. PubMed ID: 22042248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome.
    Costa AC; Grybko MJ
    Neurosci Lett; 2005 Jul; 382(3):317-22. PubMed ID: 15925111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.